INTEGRATED SEPSIS DIAGNOSTICS
Sepsis is one of the most common causes of death, with someone dying every three seconds. It is more common than death from stroke or heart attacks in the general population. The number of sepsis hospitalisations doubled in the US between 2000 and 2008. Sepsis represents a huge burden on healthcare providers, with about 1 in 10 patients in intensive care units suffering from sepsis. The cost of sepsis hospitalisations in the US was $14.6 billion in 2008.Cube Dx' Integrated Sepsis Diagnostics aids early initial sepsis diagnosis/confirmation, selection of optimal anti-infective therapy and assists monitoring of patient responses to the therapy. Biomarker-based patient monitoring supports several clinical decisions during therapy of sepsis (and other severe infections).